Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease
Sign Up to like & getrecommendations! Published in 2018 at "Materiale Plastice"
DOI: 10.37358/mp.18.3.5017
Abstract: The main aim of this study was to investigate a mixture of two poorly water-soluble active pharmaceutical ingredients (APIs): an angiotensin II receptor antagonist (valsartan) and a calcium channel blocker (amlodipine besylate), chosen in a… read more here.
Keywords: val nanoparticles; aml val; combined therapy; therapy cardiovascular ... See more keywords